---
title: "Eye Lens Maker Staar Surgical Stock Sinks As Sales Drop To $49 Million, Analyst Downgrades"
date: "2025-02-12 23:40:25"
summary: "Staar Surgical posted a Q4 2024 revenue decline due to weak China sales. The company plans cost-cutting measures."
categories:
  - "benzinga"
lang:
  - "en"
translations:
  - "en"
tags:
  - "benzinga"
menu: ""
thumbnail: "https://www.benzinga.com/files/images/story/2025/02/12/bz-pharma-briefs.jpeg"
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Staar Surgical posted a Q4 2024 revenue decline due to weak China sales. The company plans cost-cutting measures.

[benzinga](https://www.benzinga.com/general/health-care/25/02/43662652/eye-lens-maker-staar-surgical-stock-sinks-as-sales-drop-to-49-million-analyst-downgrades)
